COM:SERESTHERAPEUTICS
Seres Therapeutics, Inc.
- Stock
Last Close
0.73
22/11 21:00
Market Cap
149.43M
Beta: -
Volume Today
1.58M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | -14.85M - | -14.85M 0% | 14.82M - | |||||||||
average payables | 1.28M - | 3.78M 195.55% | 6.49M 71.68% | 7.31M 12.60% | 6.72M 8.02% | 5.64M 16.17% | 4.44M 21.26% | 8.88M 99.99% | 15.59M 75.60% | 10.54M 32.38% | ||
average receivables | 892.50K - | 5.59M 525.88% | 4.69M 15.98% | |||||||||
book value per share | -0.37 - | -0.90 140.38% | 8.73 1,072.72% | 3.33 61.86% | 1.50 54.92% | -1.18 178.58% | -0.85 27.66% | 2.19 356.75% | 1.43 34.52% | 0.10 93.04% | -0.00 100.35% | |
capex per share | -0.01 - | -0.03 475.29% | -0.19 451.45% | -0.54 190.98% | -0.12 78.57% | -0.05 58.87% | -0.02 62.79% | -0.01 58.12% | -0.10 1,308.33% | -0.09 12.89% | -0.00 99.93% | |
capex to depreciation | -1.98 - | -5.27 166.45% | -5.99 13.73% | -5.11 14.70% | -0.64 87.40% | -0.25 61.75% | -0.13 46.51% | -0.09 31.83% | -1.61 1,690.35% | -1.48 7.90% | -1.33 10.39% | |
capex to operating cash flow | 0.03 - | 0.10 195.53% | 0.11 10.51% | -0.49 558.19% | 0.06 112.65% | 0.03 50.23% | 0.01 57.51% | 0.01 51.79% | -1.43 22,755.25% | 0.04 103.00% | 0.07 58.33% | |
capex to revenue | -0.99 - | -0.15 85.25% | -0.07 52.96% | -0.03 57.62% | -0.02 38.73% | -0.07 270.96% | -1.38 1,987.41% | -0.06 95.42% | ||||
cash per share | 0.06 - | 3.83 6,803.57% | 8.71 127.29% | 4.85 44.35% | 3.71 23.54% | 2.11 43.19% | 1.67 20.54% | 3.18 89.91% | 3.17 0.27% | 1.68 47.07% | 0.00 99.94% | |
days of inventory on hand | 15.37K - | |||||||||||
days payables outstanding | 2.89K - | 6.34K 119.04% | 1.89K 70.23% | |||||||||
days sales outstanding | 18.88 - | 103.15 446.31% | ||||||||||
debt to assets | 0.39 - | 0.02 94.59% | 0.07 - | 0.10 43.69% | 0.16 66.92% | 0.34 110.88% | 0.12 64.84% | 0.14 16.65% | 0.47 236.15% | 0.31 32.77% | ||
debt to equity | -0.08 - | -0.09 24.30% | 0.14 - | 0.30 118.25% | -0.40 234.05% | -0.93 130.49% | 0.23 125.18% | 0.37 60.40% | 15.08 3,929.40% | -2.51 116.62% | ||
dividend yield | 0.00 - | |||||||||||
earnings yield | -0.00 - | -0.01 173.83% | -0.07 507.72% | -0.23 249.94% | -0.22 6.13% | -0.54 146.54% | -0.33 38.82% | -0.04 86.55% | -0.08 82.03% | -0.42 420.95% | -0.00 99.85% | |
enterprise value | 1.53B - | 1.42B 7.25% | 751.82M 47.02% | 350.68M 53.36% | 383.06M 9.23% | 105.59M 72.43% | 175.09M 65.82% | 1.88B 973.46% | 633.09M 66.32% | 604.79M 4.47% | 179.19B 29,528.24% | |
enterprise value over ebitda | -256.52 - | -105.31 58.94% | -13.71 86.98% | -4.06 70.39% | -4.55 12.18% | -1.05 76.87% | -2.56 143.53% | -21.80 750.33% | -10.10 53.67% | -2.48 75.48% | -1.66K 66,886.00% | |
ev to operating cash flow | -287.51 - | -137.00 52.35% | -18.41 86.56% | 7.98 143.38% | -5.07 163.53% | -1.68 66.88% | -2.29 36.21% | -20.08 777.48% | 94.66 571.45% | -2.64 102.79% | -1.53K 57,668.93% | |
ev to sales | 16.11 - | 11.93 25.93% | 3.74 68.70% | 5.07 35.84% | 56.59 1,015.15% | 4.37 92.28% | 84.85 1,842.31% | 1.42K 1,571.80% | ||||
free cash flow per share | -0.18 - | -0.38 106.72% | -1.92 403.63% | 0.56 129.30% | -1.98 452.24% | -1.59 19.80% | -1.37 13.95% | -1.18 13.73% | -0.03 97.34% | -2.21 6,935.52% | -0.00 99.96% | |
free cash flow yield | -0.00 - | -0.01 106.72% | -0.05 637.72% | 0.06 203.86% | -0.20 443.91% | -0.35 79.93% | -0.40 12.74% | -0.05 87.85% | -0.00 92.18% | -0.39 10,365.34% | -0.00 99.82% | |
graham net net | -0.39 - | -1.00 157.88% | 8.23 919.81% | 1.34 83.76% | 0.52 60.84% | -2.03 488.00% | -1.76 13.50% | 1.16 166.01% | 0.73 36.62% | -1.45 297.35% | -0.00 99.86% | |
graham number | 1.31 - | 3.37 156.56% | 21.38 535.27% | 13.12 38.64% | 8.64 34.16% | 8.03 7.07% | 4.67 41.88% | 7.31 56.62% | 4.65 36.34% | 2.30 50.64% | 0.00 99.88% | |
income quality | 0.87 - | 0.62 28.91% | 0.75 20.28% | -0.48 164.32% | 0.84 276.18% | 0.64 24.82% | 1.09 71.39% | 1.05 3.54% | -0.10 109.71% | 0.91 996.88% | 1.03 12.82% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -144.10 - | -98.84 - | -95.81 3.07% | -57.48 40.00% | -85.57 48.86% | -143.18 67.33% | -30.14 78.95% | -22.16 26.47% | -40.95 84.75% | 8.20 120.02% | ||
interest debt per share | 0.03 - | 0.08 184.55% | 0.02 71.95% | 0.48 1,942.52% | 0.49 1.59% | 0.50 2.75% | 0.80 58.96% | 0.55 31.49% | 0.57 3.79% | 1.56 174.49% | 0.00 99.95% | |
inventory turnover | 0.02 - | |||||||||||
invested capital | -0.08 - | -0.09 24.30% | 0.14 - | 0.30 118.25% | -0.40 234.05% | -0.93 130.49% | 0.23 125.18% | 0.37 60.40% | 15.08 3,929.40% | -2.51 116.62% | ||
market cap | 1.53B - | 1.53B 0% | 825.75M 46.05% | 394.48M 52.23% | 410.16M 3.97% | 184.16M 55.10% | 195.44M 6.12% | 1.95B 900.22% | 763.88M 60.92% | 605.23M 20.77% | 179.20B 29,509.27% | |
net current asset value | -11.54M - | -29.82M 158.52% | 196.10M 757.56% | 58.35M 70.24% | 26.25M 55.01% | -75.85M 388.90% | -80.58M 6.23% | 100.59M 224.84% | 80.28M 20.19% | -143.24M 278.43% | -228.05M 59.21% | |
net debt to ebitda | 0.14 - | 8.29 5,958.01% | 1.35 83.74% | 0.51 62.39% | 0.32 36.47% | 0.78 143.25% | 0.30 61.97% | 0.87 193.09% | 2.09 138.99% | 0.00 99.91% | 0.14 7,901.99% | |
net income per share | -0.20 - | -0.56 173.83% | -2.33 314.88% | -2.30 1.27% | -2.21 3.85% | -2.43 9.90% | -1.13 53.30% | -1.08 4.46% | -0.67 38.11% | -2.35 250.22% | -0.00 99.96% | |
operating cash flow per share | -0.18 - | -0.35 94.66% | -1.74 399.01% | 1.10 163.51% | -1.87 269.39% | -1.54 17.38% | -1.35 12.44% | -1.17 13.14% | 0.07 106.22% | -2.12 3,002.95% | -0.00 99.96% | |
payables turnover | 0.13 - | 0.06 54.35% | 0.19 235.86% | |||||||||
receivables turnover | 19.33 - | 3.54 81.70% | ||||||||||
research and ddevelopement to revenue | 3.77 - | 2.79 26.02% | 3.39 21.81% | 2.32 31.58% | 2.73 17.40% | 0.98 64.09% | 24.26 2,377.83% | 1.15 95.24% | ||||
return on tangible assets | -2.87 - | -0.14 95.04% | -0.25 77.37% | -0.34 32.99% | -0.47 40.41% | -0.82 74.15% | -0.49 40.94% | -0.25 48.03% | -0.17 31.26% | -0.73 319.94% | -0.32 56.42% | |
revenue per share | 0.55 - | 0.79 45.28% | 0.69 12.58% | 0.61 12.21% | 0.42 31.66% | 1.58 279.64% | 0.07 95.83% | 0.00 98.50% | ||||
roe | 0.55 - | 0.63 13.91% | -0.27 142.65% | -0.69 158.89% | -1.47 113.26% | 2.06 239.85% | 1.33 35.44% | -0.49 137.21% | -0.47 5.48% | -23.54 4,933.79% | 2.54 110.77% | |
roic | 0.59 - | 0.68 15.27% | -0.26 138.51% | -0.59 123.64% | -1.02 73.54% | 4.73 563.34% | -3.96 183.70% | -0.37 90.66% | -0.29 20.33% | -0.88 197.96% | -0.60 31.63% | |
sales general and administrative to revenue | 1.50 - | 1.06 29.23% | 1.15 8.74% | 0.72 37.80% | 0.93 29.18% | 0.48 48.42% | 11.18 2,239.48% | 0.69 93.79% | ||||
shareholders equity per share | -0.37 - | -0.90 140.38% | 8.73 1,072.72% | 3.33 61.86% | 1.50 54.92% | -1.18 178.58% | -0.85 27.66% | 2.19 356.75% | 1.43 34.52% | 0.10 93.04% | -0.00 100.35% | |
stock based compensation to revenue | 0.77 - | 0.54 30.16% | 0.59 8.84% | 0.24 58.92% | 0.27 9.86% | 0.14 47.48% | 3.57 2,462.07% | 0.27 92.45% | ||||
tangible asset value | -11.12M - | -26.72M 140.38% | 205.39M 868.66% | 132.63M 35.43% | 60.70M 54.23% | -48.05M 179.15% | -48.32M 0.58% | 174.75M 461.62% | 131.51M 24.75% | 10.78M 91.80% | -44.86M 515.99% | |
tangible book value per share | -0.37 - | -0.90 140.38% | 8.73 1,072.72% | 3.33 61.86% | 1.50 54.92% | -1.18 178.58% | -0.85 27.66% | 2.19 356.75% | 1.43 34.52% | 0.10 93.04% | -0.00 100.35% | |
working capital | 649K - | 109.14M 16,716.64% | 196.69M 80.22% | 167.91M 14.63% | 123.45M 26.48% | 50.62M 58.99% | 54.20M 7.06% | 222.36M 310.29% | 221.37M 0.45% | 109.17M 50.69% | 76.75M 29.69% |
All numbers in USD (except ratios and percentages)